Position Statement on Coivd-19 Vaccine AstraZeneca
The British Islamic Medical Association (BIMA) has consulted various experts in infectious diseases, the pharmaceutical industry, clinical medicine, commissioning, public health, and bioethicists to produce the following statement on the COVID 19 Vaccine AstraZeneca (hereafter referred to as the AZ Covid 19 vaccine) and how it relates to the Muslim community in Britain. This is the second vaccine that the UK Government has procured against Covid-19 to get regulatory approval by the MHRA. Following consultation with experts, this is a position statement specific to the AZ Covid-19 vaccine and is based on our knowledge at the time of publication. This is a rapidly evolving situation with more vaccines expected to be made available and more clinical trial data pending publication. We may revise our statement should the evidence compel us to do so.
We recommend the COVID 19 Vaccine AstraZeneca for eligible individuals in the Muslim community for protection against Covid-19 when used in accordance with the MHRA authorisation.
